You are here

Therapeutic Advances in Endocrinology and Metabolism

Therapeutic Advances in Endocrinology and Metabolism


eISSN: 20420196 | ISSN: 20420188 | Current volume: 14 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Launched in 2010.
  • Gold open access journal – all articles are made freely available online immediately upon publication.
  • Rigorous peer review.
  • Indexed in Clarivate Analytics: Science Citation Index Expanded (SCIE), Scopus, ProQuest, and PubMed Central.
  • Over 270,000 full-text article views annually.

Therapeutic Advances in Endocrinology and Metabolism (TAEM) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of endocrinology and metabolism. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Endocrinology and Metabolism (TAEM) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the endocrinology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/tae.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access information

Unsolicited manuscripts submitted to Therapeutic Advances in Endocrinology and Metabolism (TAEM) are subject to an article processing charge (APC). The APC for this journal is currently $2,800 USD payable on acceptance. The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to endocrinology@sagepub.co.uk.

This journal changed its publication mode from subscription to open access in 2019.

Therapeutic Advances in Endocrinology and Metabolism delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of endocrine and metabolic conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in endocrinology, diabetic medicine and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). Therapeutic Advances in Endocrinology and Metabolism conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; and Online First publication is usually within 3 weeks of Acceptance.

Editor-in-Chief
Christoph Schindler Hannover Medical School, Hannover, Germany
Deputy Editor in Chief
Srikanth Bellary Aston University, Birmingham, UK
Editor
Sarangi Thattyot Kariyath SAGE Publications
Associate Editors
Stefan Engeli University Medicine Greifswald, Greifswald, Germany
Peter Godsk Jørgensen Herlev and Gentofte Hospital, Copenhagen, Denmark
Joanna Klubo-Gwiezdzinska Georgetown University Hospital – MedStar Washington Hospital, Washington, USA
Brendan Nolan University of Melbourne, Melbourne, Australia
Micol Rothman University of Colorado Medicine, Denver, USA
Editorial Board
Clifford J Bailey Aston University, Birmingham, UK
Pierre-Marc Bouloux Royal Free Hospital, London, UK
Ada Cheung The University of Melbourne, Melbourne, Australia
Raffaele Ivan Cincione University of Foggia, Italy
Ryan Crews Rosalind Franklin University of Medicine and Science, Illinois USA
Ketan Dhatariya Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk, UK
Juan Espinoza Children's Hospital Los Angeles, California, USA
Neil Gittoes Queen Elizabeth Hospital, Birmingham, UK
Cheng Han Albert Einstein College of Medicine, New York, NY, USA
Shariful Islam Deakin University, Melbourne, Australia
Anupam Kotwal, MD University of Nebraska Medical Center, Omaha, USA
Sandro La Vignera University of Catania Policlinico “G. Rodolico”, Catania, Italy
Martha Lappas The University of Melbourne, Melbourne, Australia
Philippe Lysy UCLouvain, Brussels, Belgium
Rayaz Malik University of Manchester, Manchester, UK
Chantal Mathieu Katholieke Universiteit Leuven, Flanders, Belgium
Eugene McCloskey University of Sheffield, Sheffield, UK
Teh Ming Ming SingHealth Duke-NUS Diabetes Centre Singapore General Hospital Singapore
Matilde Monteiro-Soares University of Porto, Porto, Portugal
Mototsugu Nagao Nippon Medical School Hospital, Tokyo, Japan
Rimesh Pal Post Graduate Institute of Medical Education and Research, Chandigarh, India
Francesco Paneni University of Zürich, Zürich, Switzerland
Gregory Pastores University College Dublin, Dublin, Ireland
Ankit Patel Harvard Medical School, Boston, USA
Richard Quinton Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Jinnie Rhee Stanford University School of Medicine, California, USA
Thozhukat Sathyapalan University of Hull, Kingston upon Hull, UK
Mark Sherlock Beaumont Hospital, Dublin, Ireland
Ashish Verma Boston University School of Medicine, Boston, USA
Jack A. Yanovski National Institutes of Health, Bethesda, USA
Editorial Review Board
Alberto Falchetti, MD ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Daya Ram Pokharel, PhD Manipal College of Medical Sciences, Nepal
Szymon Suwala, MD, PhD Collegium Medicum, Nicolaus Copernicus University, Torun, Poland
Miguel Angel Maria Tablado, MD Gerencia Atención Primaria, SERMAS, Madrid, Spain
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.

    Subscription Information

     

    To subscribe to this journal or to purchase single/back issues, please contact Customer Service - Journals: customerservicejournals@sagepub.in  +91 (11) 4063 9222 extn 406


    To purchase bundled content, backfiles or any other electronic products, please contact: journalsales@sagepub.in


    For exciting offers and deals, write to: jmarketing@sagepub.in